
BlackRock (BLK) is poised to release its Q2 earnings on July 15, with analysts projecting year-over-year growth to $10.60 EPS and $5.41 billion in revenue. The asset manager recently announced its intent to acquire ElmTree Funds, a strategic move preceding a slight 0.6% dip in its shares on Monday. Despite this minor pullback, the majority of prominent analysts, including Wells Fargo, Morgan Stanley, Goldman Sachs, and Argus Research, have reiterated positive ratings and raised their price targets, signaling robust confidence in BLK's future performance, although UBS notably lowered its target to $980.
BlackRock (BLK) is approaching its second-quarter earnings release with consensus expectations pointing to a significant 12.7% year-over-year revenue increase to $5.41 billion, while earnings per share are forecasted to grow more modestly by 2.3% to $10.60. This juxtaposition of strong top-line growth against slower bottom-line expansion will be a key area of focus. The company's recent strategic move to acquire ElmTree Funds signals continued growth ambitions. Despite a minor 0.6% share price decline to $1,075.97 ahead of the report, analyst sentiment is predominantly bullish. Four high-accuracy analysts from firms including Wells Fargo and Morgan Stanley have recently reaffirmed Overweight or Buy ratings, raising price targets to as high as $1,180. This positive consensus is contrasted by an older, more cautious Neutral rating from UBS in April, which lowered its price target to $980, below the current trading level.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.60
Ticker Sentiment